The last decade has seen a renaissance of the concept of individualized chemotherapy in oncology, markedly stimulated by the development of new in vitro chemosensitivity assays. The clinical utility of drug response assays has been evaluated in clinical trials and the results suggest that assay-assisted therapy selection may improve survival as well as economic outcomes. This volume comprises the proceedings of the first Symposium of the International Society for Chemosensitivity Testing in Oncology, ISCO-1, held in Homburg/Saar, Germany, in September 2001. The topics include: new in vitro drug-testing methods, tumor chemosensitivity assays, and the clinical relevance of assay-directed therapy.
Chemosensitivity Testing in Oncology
and over one million other books are available for Amazon Kindle.
Learn more
FREE Two-Day Shipping for students on millions of items. Learn more |
| ||||||||||||||||||
Book Description
Product Details
Would you like to update product info or give feedback on images?
|
Customer Reviews
|
There are no customer reviews yet.
|
|||
|
Video reviews
|
Inside This Book
(learn more)
First Sentence:
Preclinical research and development of new chemotherapeutic drugs requires both in vitro and in vivo assay systems to test drug activity against different types of tumor cells. Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
triphosphate luminescence assay, cellular drug resistance profiles, prednisolone resistance, drug response assay, test drug concentration, tumor chemosensitivity assay, chemosensitivity testing, vitro cellular drug resistance, nonclonogenic assays, adjuvant cancer chemotherapy, cytoprint assay, vivo chemosensitivity, recurrent ovarian cancer, human tumor stem cells, vitro chemosensitivity test, chemosensitivity assays, individualized chemotherapy, metastatic cutaneous melanoma, chemosensitivity profile, vitro drug resistance, chemosensitivity tests, vitro drug sensitivity testing, clinical pilot trial, metastatic melanoma patients, assay end points Key Phrases - Capitalized Phrases (CAPs): (learn more)
Cancer Res, Clin Oncol, Van Wering, Springer-Verlag Berlin Heidelberg, Van Zantwijk, Gynecol Oncol, Melanoma Res, Surg Oncol, Natl Cancer Inst, Biosens Bioelectron, Cancer Chemother Pharmacol, Invest Dermatol, Ramakers-Van Woerden, Vindesine Resistant, Cancer Lett, Cancer Treat Rep, Cisplatin Resistant, Dutch Childhood Leukemia Study Group, Nitta Gelatin Inc, Drug Resistance Mediated, Early Clinical Trials, Gene Transcription, Schlagbauer Wadi, Ann Oncol, Arch Gynecol Obstet New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Preclinical research and development of new chemotherapeutic drugs requires both in vitro and in vivo assay systems to test drug activity against different types of tumor cells. Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
triphosphate luminescence assay, cellular drug resistance profiles, prednisolone resistance, drug response assay, test drug concentration, tumor chemosensitivity assay, chemosensitivity testing, vitro cellular drug resistance, nonclonogenic assays, adjuvant cancer chemotherapy, cytoprint assay, vivo chemosensitivity, recurrent ovarian cancer, human tumor stem cells, vitro chemosensitivity test, chemosensitivity assays, individualized chemotherapy, metastatic cutaneous melanoma, chemosensitivity profile, vitro drug resistance, chemosensitivity tests, vitro drug sensitivity testing, clinical pilot trial, metastatic melanoma patients, assay end points Key Phrases - Capitalized Phrases (CAPs): (learn more)
Cancer Res, Clin Oncol, Van Wering, Springer-Verlag Berlin Heidelberg, Van Zantwijk, Gynecol Oncol, Melanoma Res, Surg Oncol, Natl Cancer Inst, Biosens Bioelectron, Cancer Chemother Pharmacol, Invest Dermatol, Ramakers-Van Woerden, Vindesine Resistant, Cancer Lett, Cancer Treat Rep, Cisplatin Resistant, Dutch Childhood Leukemia Study Group, Nitta Gelatin Inc, Drug Resistance Mediated, Early Clinical Trials, Gene Transcription, Schlagbauer Wadi, Ann Oncol, Arch Gynecol Obstet New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Citations (learn more)
This book cites 5
books:
- Breast Cancer (Atlas of Clinical Oncology) by Clifford A. Hudis M.D. on page 144
- Cutaneous Melanoma by Charles M. Balch on page 108
- CUTANEOUS MELANOMA: Clinical Management and Treatment Results Worldwide by Charles M. Balch on page 108
- San Antonio (Gousha Fastmap) by Gousha on page 158
- Ovarian Cancer (Cancer Treatment and Research) by David S. Alberts on page 126
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
Listmania!
So You'd Like to...
Look for Similar Items by Category
- Books > Health, Fitness & Dieting > Disorders & Diseases > Cancer
- Books > Medical Books > Medicine > Internal Medicine
- Books > New & Used Textbooks > Medicine & Health Sciences > Medicine > Clinical > Oncology
- Books > New & Used Textbooks > Science & Mathematics > Biology & Life Sciences
- Books > Science & Math > Biological Sciences
